Advertisement

Psychopharmacology

, Volume 116, Issue 2, pp 173–182 | Cite as

Effects of two stressors on behaviour in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT

  • James W. McBlane
  • Sheila L. Handley
Article

Abstract

Effects of water deprivation and restraint were compared in the rat elevated X-maze. Water deprivation for 12–48 h increased corticosterone and had a duration-dependent “anxiolytic” effect in the elevated X-maze, increasing the ratio of open/total arm entries (OTR) and the proportion of time spent on the open arms (% time) without affecting total entries. Brain 5HIAA/5HT was increased only after 24 or 48 h deprivation. Restraint for 15 min also increased plasma corticosterone and brain 5HIAA/5HT but had no effect on behaviour in the elevated X-maze when rats were tested immediately afterwards. However, 1 h restraint was “anxiogenic” in the elevated X-maze immediately after release, reducing OTR and % time, but with a less consistent reduction in total entries; reductions in OTR and % time were still present 24 h later. The 5HT1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) (0.1–0.2 mg/kg), administered 10 min before testing in the elevated X-maze, had “anxiogenic” actions in non-stressed rats. The effect of 0.1 mg/kg 8-OH-DPAT was not significantly altered by 24 or 48 h water deprivation but was abolished by restraint for 1 h immediately beforehand, despite the “anxiogenic” effect of restraint alone. Similar mutual antagonism of 8-OH-DPAT and restraint occurred when the dose of 8-OH-DPAT was increased to 0.2 mg/kg. Twenty-four hours after restraint, restrained rats which had received 8-OH-DPAT (0.1–0.2 mg/kg) still did not show any significant “anxiogenic effect” compared with non-restrained vehicle treated controls. Restraint-induced deficits in elevated X-maze exploration may prove a useful model with which to study the pharmacology of depression-related anxiety. However, the effects of the stressors examined, and their interaction with 8-OH-DPAT in the elevated X-maze, appear to depend on the nature of the stressor.

Key words

5HT1A receptor 8-OH-DPAT Stress Anxiety Elevated X-maze 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amsterdam JD (1992) Gepirone, a selective serotonin (5HT1A) partial agonist in the treatment of major depression. Prog Neuropsychopharmacol Biol Psychiatry 16:271–280Google Scholar
  2. Bliss EL, Ailion J, Zwanziger J (1968) Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress. J Pharmacol Exp Ther 164:122–134Google Scholar
  3. Carli M. Samanin R (1988) Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist. Psychopharmacology 94:84–91Google Scholar
  4. Carli M, Pronterra C, Samanin, R (1989) Effect of 5HT1A agonists on stress-induced deficit in open field locomotor activity of rats: evidence that this model identifies anxiolytic-like activity. Neuropharmacology 28: 471–476Google Scholar
  5. Crawley JN (1981) Neuropharmacological specificity of a simple animal model to the behavioural actions of the benzodiazepines. Pharmacol Biochem Behav 15:695–699Google Scholar
  6. Critchley MAE, Handley SL (1987) Effects in the X-maze anxiety model of agents acting at 5HT1 and 5HT2 receptors. Psychopharmacology 93:502–506Google Scholar
  7. Critchley MAE, Njung'e K, Handley, SL (1992) Actions and some interactions of 5HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions. Psychopharmacology 106:484–490Google Scholar
  8. Deakin JFW (1983) Role of serotonergic systems in escape, avoidance and other behaviours. In: Cooper SJ (ed) Theory in psychopharmacology Vol. 2. Academic Press, London, pp 149–193Google Scholar
  9. Deakin JFW (1991) The clinical relevance of animal models of depression. In: Willner P (ed) Behavioural models in psychopharmacology; theoretical, industrial and clinical perspectives. Cambridge University Press, Cambridge, pp 157–174Google Scholar
  10. Deakin JFW, Graeff FG (1991) 5HT and mechanisms of defence. J Psychopharmacol 5:305–315Google Scholar
  11. Dickinson SL, Kennett GA, Curzon G (1985) Reduced 5-hydroxytryptamine-dependent behaviour in rats following chronic corticosterone treatment. Brain Res 345:10–18Google Scholar
  12. Duncan GE, Oglesby SA, Greenwood RS, Meeker RB, Hayward JN, Stumpf WE (1989) Metabolic mapping of functional activity in rat brain during water deprivation. Neuroendocrinology 49:489–495Google Scholar
  13. Dunn RW, Corbett R, Fielding S (1989) Effects of 5HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 169:1–10Google Scholar
  14. Engel JA, Hjörth S, Svensson K, Carlsson A, Liljeqvist S (1984) Anticonflict effects of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Eur J Pharmacol 105:365–368Google Scholar
  15. Falter U, Gower AJ, Gobert J (1992) Resistance of baseline activity in the elevated plus-maze to exogenous influences. Behav Pharmacol 3:123–128Google Scholar
  16. File SE, Hyde J (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62:19–24Google Scholar
  17. File SE, Johnston AL, Baldwin HA (1988) Anxiolytic and anxiogenic drugs: changes in behaviour and endocrine responses. Stress Med 4:221–230Google Scholar
  18. Frances A, Manning D, Marin D, Kocis J, McKinney K, Hall W, Kline M (1992) Relationship of anxiety and depression. Psychopharmacology 106:S82-S86Google Scholar
  19. Guimaraes FS (1993) 5HT receptors and consolidation of stressful memories. Behav Brain Res (in press)Google Scholar
  20. Handley SL (1991) Serotonin in animal models of anxiety-the importance of stimulus and response. In: Idzikowski C, Cowen PJ (eds) Serotonin, sleep and mental disorders. Wrightson Biomedical Publishing, Chichester, pp 89–115Google Scholar
  21. Handley SL, McBlane JW (1991) 5HT-the disengaging transmitter? J Psychopharmacol 5:321–326Google Scholar
  22. Handley SL, McBlane JW (1993a) An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J Pharmacol Toxicol Meth 29:129–138Google Scholar
  23. Handley SL, McBlane JW (1993b) 5HT drugs in animal models of anxiety. Psychopharmacology 112:13–20Google Scholar
  24. Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze exploration model of “fear”-motivated behaviour. Naunyn-Schmiedebergs Arch Pharmacol 327:1–5Google Scholar
  25. Hjörth S, Magnusson T (1988) The 5HT1A receptor agonist 8-OH-DPAT preferentially activates cell body 5HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 338:463–471Google Scholar
  26. Hodges JR, Jones MT (1963) The effect of injected corticosterone on the release of adrenocorticotrophic hormone in rats exposed to acute stress. J Physiol 167:30–37Google Scholar
  27. Iversen SD (1984) 5HT and anxiety. Neuropharmacology 23:1553–1560Google Scholar
  28. Johnson EO, Kamilaris TC, Chrousos GP, Gold PW (1992) Mechanism of stress: a dynamic overview of hormonal and behavioural homeostasis. Neurosci Biobehav Rev 16:115–130Google Scholar
  29. Joseph MJ, Kennett GA (1983) Stress-induced release of 5HT in the hippocampus and its dependence on increased tryptophan availability: an in vivo electrochemical study. Brain Res 330:251–257Google Scholar
  30. Kabra PM, Tsai L-L, Marton LJ (1979) Improved liquid-chromatographic method for determination of serum cortisol. Clin Chem 25:1293–1296Google Scholar
  31. Kennett GA, Joseph MH (1981) The functional importance of increased brain tryptophan in the serotonergic response to restraint stress. Neuropharmacology 20:39–43Google Scholar
  32. Kennett GA, Dickinson SL, Curzon G (1985) Enhancement of some 5HT dependent behavioural responses following repeated immobilization in rats. Brain Res 330:253–263Google Scholar
  33. Kennett GA, Dourish CT, Curzon G (1987) Anti-depressant-like action of 5HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol 134:265–274Google Scholar
  34. Kennett GA, Chaouloff F, Marcou M, Curzon G (1986) Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin. Brain Res 382:416–421Google Scholar
  35. Knott PJ, Curzon G (1974) Effect of increased rat brain tryptophan on 5-hydroxytryptamine and 5-hydroxyindolyl acetic acid in the hypothalamus and other brain regions. J Neurochem 32:1065–1071Google Scholar
  36. Knott PJ, Joseph MH, Curzon G (1973) Effects of food deprivation and immobilization on tryptophan and other amino acids in rat brain. J Neurochem 20:249–251Google Scholar
  37. Kostowski W, Platznik A, Stefanski R (1989) Intra-hippocampal buspirone in animal models of anxiety. Eur J Pharmacol 168:393–396Google Scholar
  38. Kumar AM, Kumar M, Deepika K, Fernandez JB, Eisdorfer C (1990) A modified HPLC technique for similtaneous measurement of 5-hydroxytryptamine and 5-hydroxyindole acetic acid in cerebrospinal fluid, platelet and plasma. Life Sci 47:1751–1759Google Scholar
  39. Lima L (1991) Region-selective reduction of brain serotonin turnover rate and serotonin agonist-induced behaviour in mice treated with clonazepam. Pharmacol Biochem Behav 39:671–676Google Scholar
  40. Linton M, Gallo PS Jr (1975) The practical statistician. Brooks/Cole, CaliforniaGoogle Scholar
  41. Lister RG (1990) Ethologically-based animal models of anxiety disorders. Pharmacol Ther 46:321–340Google Scholar
  42. Luscombe GP, Mazurkiewicz S, Buckett WR (1990) Evaluation of tricyclic antidepressants in the elevated plus-maze in rats: anxiolytic effect of dothiepin and doxepin. Br J Pharmacol 100:356PGoogle Scholar
  43. Mendelson SD, McEwen BS (1991) Autoradiographic analyses of the effects of restraint-induced stress on 5HT1A, 5HT1C and 5HT2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinology 54:454–461Google Scholar
  44. Mitchell SN, Thomas PJ (1988) Effect of restraint stress and anxiolytics on 5HT turnover in rat brain. Pharmacology 37:105–113Google Scholar
  45. Montgomery KC (1955) The relation between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol Psychol 48:254–260Google Scholar
  46. Morgan WW, Rudeen K, Pfell KA (1975) Effect of immobilization stress on serotonin content and turnover in regions of the rat brain. Life Sci 17:143–150Google Scholar
  47. Moser PC (1989) An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology 99:48–53Google Scholar
  48. Njung'e K, Critchley MAE, Handley SL (1993) Effects of beta-adrenoceptor ligands in the elevated X-maze “anxiety” model and antagonism of the “anxiogenic” response to 8-OH-DPAT. J Psychopharmacol 7:173–180Google Scholar
  49. Nutt DJ, Gule P (1989) Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective. Pharmacol Ther 44:309–334Google Scholar
  50. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14:149–167Google Scholar
  51. Pellow S, Johnston AL, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG7142 using the elevated plus maze in the rat. J Pharm Pharmacol 39:917–928Google Scholar
  52. Piezzi RS, Wurtman RJ (1970) Pituitary serotonin content: effects of melatonin or deprivation of water. Science 169:285–286Google Scholar
  53. Schweitzer EE, Amsterdam JA, Rickels K, Kaplan M, Droba M (1986) Open trial of buspirone in the treatment of major depressive disorders. Psychopharmacol Bull 22:183–185Google Scholar
  54. Shimizu N, Oomura Y, Kai Y (1989) Stress-induced anorexia in rats mediated by serotonergic mechanisms in the hypothalamus. Physiol Behav 46:835–841Google Scholar
  55. Söderpalm B, Hjorth S, Engel JA (1989) Effects of 5HT1A receptor agonists andl-5HTP in Montgomery's conflict test. Pharmacol Biochem Behav 32:259–265Google Scholar
  56. Stavrakaki C, Vargo B (1986) The relationship between anxiety and depression: a review of the literature. Br J Psychiatry 149:7–16Google Scholar
  57. Thierry AM, Fekete M, Glowinski J (1968) Effects of stress on the metabolism of noradrenaline, dopamine and serotonin (5HT) in the central nervous system of the rat. (II) Modifications of serotonin metabolism. Eur J Pharmacol 4:384–389Google Scholar
  58. Tizabi Y, Gilad VH, Gilad GM (1989) Effects of chronic stressors or corticosterone treatment on the septohippocampal cholinergic system of the rat. Neurosci Lett 105:177–183Google Scholar
  59. Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing antianxiety agents. Psychopharmacologia 21:1–7Google Scholar
  60. Wilkinson LO, Jacobs BL (1988) Lack of response of serotonergic neurons in the dorsal raphe nucleus of freely moving cats to stressful stimuli. Exp Neurol 101:445–457Google Scholar
  61. Wilkinson LO, Auerbach SB, Jacobs BL (1991) Extracellular serotonin levels change with behavioural state but not with pyrogen-induced hyperthermia. J Neurosci 11:2732–2741Google Scholar
  62. Willner P (1984) The validity of animal models of depression. Psychopharmacology 83:1–16Google Scholar
  63. Wright IK, Heaton M, Upton N, Marsden CA (1992) Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze. Psychopharmacology 107:405–414Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • James W. McBlane
    • 1
  • Sheila L. Handley
    • 1
  1. 1.Pharmaceutical Sciences InstituteAston University, Aston TriangleBirminghamUK

Personalised recommendations